In an increasingly globalised healthcare landscape, the demand for accurate, high-quality data from international quantitative research is greater than ever. As we navigate 2024, new trends are emerging that are reshaping how healthcare research is conducted on a global scale. From AI-driven data collection to the rise of patient-centric studies, staying ahead of these trends is important for organisations looking to make data-backed decisions.
At M3 Global Research, we have our finger on the pulse of these trends, leveraging the world’s largest ISO-certified panel of healthcare professionals to provide unmatched data quality, fraud prevention, and rapid turnaround times. In this blog, we’ll explore some of the key trends shaping international quantitative research in healthcare for 2024, and how M3 is leading the charge.
1. The Rise of Artificial Intelligence (AI) and Machine Learning in Healthcare Market Research
AI and machine learning are changing the landscape of quantitative research. In 2024, we are seeing an increased use of AI for real-time data analysis, pattern recognition, and predictive analytics, particularly in global healthcare research. These technologies allow researchers to quickly process large datasets from multiple regions, identifying key trends and delivering faster insights.
At M3, we have initially integrated AI and machine learning into our research processes in two ways to help our clients gather actionable insights more efficiently, whilst ensuring the highest quality data. Our fraud detection applications use AI technology to identify potentially fraudulent respondents via detailed algorithms developed to identify bad actors. AI also powers our dynamic audiences, where sampling now incorporates millions of data points rather than basic demographic information, reducing screenouts, and speeding up fieldwork. These technologies, combined with our global panel of healthcare professionals, ensures that you get both speed and scale for your international studies.
2. Patient-centric Research
Another significant trend in 2024 has been the continued rise of patient-centric research, driven by the increasing demand for personalised medicine and treatments. International healthcare studies are increasingly focusing on patient experiences and outcomes, which means researchers need access to diverse patient populations across different regions.
M3’s quantitative research capabilities enable you to gather patient and physician data, ensuring a 360-degree view of healthcare outcomes. Our dynamic profiling and personalised invitations ensure that you’re reaching the right participants, regardless of their location.
3. Data Integrity in Global Markets
As international research expands, so do the challenges of maintaining data integrity across multiple regions. Fraud prevention and respondent verification are top priorities for global healthcare research. With an increase in survey fraud and data duplication risks, it’s more important than ever to ensure that only verified healthcare professionals participate in your studies.
At M3, we combine cutting-edge fraud prevention technologies, including Google reCAPTCHA and Imperium’s RelevantID, with our own proprietary systems to maintain data quality across borders. Our triple-verified panelists and global reach ensure that your data is reliable and trustworthy.
4. Speed Meets Scale: The Growing Demand for Rapid Turnaround Times
Where healthcare innovations are happening at a rapid speed, waiting weeks or months for research data is no longer an option. International healthcare companies require fast, actionable insights to stay ahead of competition, drive strategy, and make informed decisions. In 2024, the ability to collect high-quality global data in a short time has become a key factor in market research.
M3 Global Research is at the forefront of this trend with M3 Agile—our high-speed, cost-effective research solution. Whether you're conducting physician or patient research across the US, EU5, or APAC, M3 Agile delivers insights within 48 hours post-launch, without compromising data quality. This service is ideal for organisations that need to move fast while still ensuring precision in global markets.
5. Global Collaboration and Cross-Cultural Insights
Healthcare systems vary greatly between regions, and these differences must be accounted for in international quantitative research. In 2024, successful global studies will focus not just on collecting data, but on understanding the cultural, regulatory, and healthcare system nuances that drive differences in responses across markets.
At M3 Global Research, our ISO-certified panel is not only the largest in the world, but it is also diverse in terms of geography and specialty. This allows us to provide deeper insights that consider local healthcare policies, treatment practices, and cultural influences. We ensure that your research not only spans multiple markets but also reflects the distinct healthcare realities in each region, providing you with nuanced, actionable insights.
M3 Global Research—Your Partner in International Quantitative Healthcare Research
As healthcare research continues to globalise, the need for precision, speed, and cultural understanding is paramount. M3 combines these strengths with the world’s largest ISO-certified panel of triple-verified healthcare professionals, advanced fraud prevention technologies, and cutting-edge tools like M3 Agile for rapid insights. Whether you're exploring emerging markets, analysing patient behaviours, or investigating physician perspectives, M3 is your trusted partner for reliable, high-quality data in international healthcare research.
Stay ahead of the trends shaping the future of healthcare by partnering with M3 Global Research for your next international quantitative study. Let us provide the data and insights you need to navigate a rapidly changing world.
Are you interested in learning more?
